| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0077 | 1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |